In reply to @polybiorf

4/ This trial of low-dose rapamycin is actively recruiting a few final participants with Long COVID. A recent expansion to the trial from Vitalik Buterin’s Balvi Fund provides an opportunity to severe Long COVID patients to participate via at-home visits. https://polybio.org/funding-from-vitalik-buterins-balvi-fund-expands-long-covid-rapamycin-trial/